Infectious disease experts weigh in on how they are personally dealing with the pandemic. Elizabeth Connick, MD, chief of the division of infectious diseases and professor of medicine and immunobiology at the College of Medicine – Tucson, discusses dining indoors with The Washington Post.

“Celebrating Life & Science” is a special one-hour broadcast event highlighting inspiring stories of Arizonans working together and using science to make life better for people everywhere. Arizona Bioscience Researcher of the Year Janko Nikolich-Žugich, MD, PhD, department head and professor of immunobiology at the College of Medicine – Tucson, is featured.

Public health experts say the rate of teenage vaccination can be a signpost on whether parents will get younger children vaccinated. “If we had a robust response to vaccinations in the 12 to 17 age group, I would hold a lot of hope for this new vaccination expansion,” said doctor and advocate Ruth Franks Snedecor, MD, clinical assistant professor at the College of Medicine – Phoenix.

University of Arizona Cancer Center researchers recently found a promising method to battle cancer, slow its growth and overcome drug resistance. Noel Warfel, PhD, an associate professor of Cellular and Molecular Medicine at the College of Medicine – Tucson, is leading the study.

Michael Badowski, PhD, an associate research scientist at the University of Arizona Health Sciences Biorepository, writes that the response to the COVID-19 outbreak has better prepared global infrastructure for a more deadly pandemic.

The National Institutes of Health -unded network aims to develop more effective brain-aging treatments and interventions targeted to the individual.

Researchers find lower immune response to COVID-19 vaccine for patients on chemotherapy; third dose of Pfizer-BioNTech vaccine boosts immune response.

The grant will help address COVID-19 disparities among racial and ethnic minority populations and rural communities in Arizona.

Murtaza Akhter, MD, an emergency medicine physician at the College of Medicine – Phoenix, discusses the stress on doctors and nurses in hospitals in states hardest hit by the covid delta surge.

New research at the University of Arizona Health Sciences found that patients undergoing active chemotherapy had a lower immune response to two doses of the COVID-19 vaccine, but a third dose increased response. "We wanted to make sure we understand the level of protection the COVID-19 vaccines are offering our cancer patients, especially as restrictions were being eased and more contagious variants were starting to spread," said Rachna Shroff, MD, MS, chief of Gastrointestinal Medical Oncology at the UArizona Cancer Center and director of the Cancer Center Clinical Trials Office.